|
ID
|
Author
|
Year
|
Title
|
Publisher
|
| 1195769 |
Blank, Patricia R.; Freiburghaus, Andreas U.; Ruf, Bernhard R.; Schwenkglenks, Matthias M.; Szucs, Thomas D. |
2008 |
Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07 |
Medizinische Klinik |
| 1194551 |
Pettengell, Ruth; Schwenkglenks, Matthias; Leonard, Robert; Bosly, André; Paridaens, Robert; Constenla, Manuel; Szucs, Thomas D; Jackisch, Christian; Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU) |
2008 |
Neutropenia occurrence and predictors of reduced chemotherapy delivery : results from the INC-EU prospective observational European neutropenia study |
Supportive care in cancer |
| 1194565 |
Blijlevens, Nicole; Schwenkglenks, Matthias; Bacon, Pamela; D'Addio, Alessandra; Einsele, Hermann; Maertens, Johan; Niederwieser, Dietger; Rabitsch, Werner; Roosaar, Ann; Ruutu, Tapani; Schouten, Harry; Stone, Rebecca; Vokurka, Samuel; Quinn, Barry; McCann, Shaun |
2008 |
Prospective oral mucositis audit : oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy : european blood and marrow transplantation mucositis advisory group |
Journal of clinical oncology |
| 1195770 |
Kunze, Ursula |
2008 |
Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey |
Wiener medizinische Wochenschrift |
| 1195771 |
Szucs, Thomas D. |
2008 |
Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons |
BMC Public Health |
| 1193154 |
Pettengell, Ruth; Bosly, André; Szucs, Thomas D; Jackisch, Christian; Leonard, Robert; Paridaens, Robert; Constenla, Manuel; Schwenkglenks, Matthias; Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU) |
2009 |
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma : data from the INC-EU Prospective Observational European Neutropenia Study |
British journal of haematology : the official journal of the British Society for Haematology and the European Haematology Association |
| 1196876 |
McCann, S; Schwenkglenks, M; Bacon, P; Einsele, H; D'Addio, A; Maertens, J; Niederwieser, D; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Stone, R; Vorkurka, S; Quinn, B; Blijlevens, N; EBMT Mucositis Advisory Group |
2009 |
The Prospective Oral Mucositis Audit : relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT |
Bone marrow transplantation |
| 1196343 |
Romanens, Michel; Ackermann, Franz; Abay, Michael; Szucs, Thomas; Schwenkglenks, Matthias |
2009 |
Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions |
Cardiovascular drugs and therapy |
| 1194548 |
Dedes, Konstantin J; Matter-Walstra, Klazien; Schwenkglenks, Matthias; Pestalozzi, Bernhard C; Fink, Daniel; Brauchli, Peter; Szucs, Thomas D |
2009 |
Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer : an economic evaluation |
EJC : European journal of cancer |
| 1196875 |
Blank, P. R.; Schwenkglenks, M.; Szucs, T. D. |
2009 |
Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons |
Infection |
| 1193153 |
Blank, Patricia R; Schwenkglenks, Matthias; Szucs, Thomas D |
2009 |
Vaccination coverage rates in eleven European countries during two consecutive influenza seasons |
The journal of infection |
| 1194550 |
Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Culakova, Eva; Lyman, Gary H |
2010 |
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery |
Journal of hematology & oncology |
| 789198 |
Matter-Walstra, K. W.; Dedes, K. J.; Schwenkglenks, M.; Brauchli, P.; Szucs, T. D.; Pestalozzi, B. C. |
2010 |
Trastuzumab beyond progression: a cost-utility analysis |
Annals of Oncology |
| 1193843 |
Blank, Patricia R; Schwenkglenks, Matthias; Moch, Holger; Szucs, Thomas D |
2010 |
Human epidermal growth factor receptor 2 expression in early breast cancer patients : a Swiss cost-effectiveness analysis of different predictive assay strategies |
Breast cancer research and treatment |
| 1194525 |
Joerger, Markus; Matter-Walstra, Klazien; Früh, Martin; Kühnel, Ursula; Szucs, Thomas D.; Pestalozzi, Bernhard; Schwenkglenks, Matthias |
2011 |
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis |
Annals of oncology |
| 1193841 |
Haioun, Corinne; Salar, Antonio; Pettengell, Ruth; Johnsen, Hans Erik; Duehrsen, Ulrich; Rossi, Francesca Gaia; Verhoef, Gregor; Schwenkglenks, Matthias; Jaeger, Ulrich; Hamilton, Lisa; Pujol, Beatriz; Lugtenburg, Pieternella Johanna |
2011 |
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy : results from an observational study |
Leukemia & lymphoma |
| 1194549 |
Loibl, Sibylle; Skacel, Tomas; Nekljudova, Valentina; Lück, Hans Joachim; Schwenkglenks, Matthias; Brodowicz, Thomas; Zielinski, Christoph; von Minckwitz, Gunter |
2011 |
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis |
BMC cancer |
| 1195225 |
Schwenkglenks, Matthias; Pettengell, Ruth; Jackisch, Christian; Paridaens, Robert; Constenla, Manuel; Bosly, André; Szucs, Thomas D; Leonard, Robert |
2011 |
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients : data from the INC-EU Prospective Observational European Neutropenia Study |
Supportive care in cancer |
| 1194534 |
Tomonaga, Yuki; Gutzwiller, Felix; Lüscher, Thomas F; Riesen, Walter F; Hug, Markus; Diemand, Albert; Schwenkglenks, Matthias; Szucs, Thomas D |
2011 |
Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care : a cluster-randomised controlled trial |
BMC family practice |
| 1194531 |
Szucs, T. D.; Blank, P. R.; Schwenkglenks, M.; Aapro, M. |
2011 |
Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia |
Oncology |
